Literature DB >> 32128852

LINC00174 is an oncogenic lncRNA of hepatocellular carcinoma and regulates miR-320/S100A10 axis.

Jin-Tao Zhao1, Bao-Jin Chi2, Yao Sun3, Nan-Nan Chi1, Xue-Mei Zhang1, Jia-Bin Sun4, Ying Chen4, Yong Xia5.   

Abstract

Hepatocellular carcinoma (HCC) is one of the deadliest cancers. Multiple long non-coding RNAs (lncRNAs) are recently identified as crucial oncogenic factors or tumour suppressors. In this study, we explored the effects of LINC00174 on the progression of HCC. Expression levels of LINC00174 and microRNA-320 (miR-320) in HCC tissue samples were measured using quantitative real-time polymerase chain reaction (qRT-PCR). The association between pathological indices and LINC00174 was also analysed. Human HCC cell lines Hep3B and Huh7 were used as cell models. CCK-8 and bromodeoxyuridine (BrdU) assays were used to assess the effect of LINC00174 on HCC cell line proliferation. Flow cytometry was used to study the effect of LINC00174 on HCC apoptosis. Transwell assay was conducted to detect the effect of LINC00174 on migration and invasion. Furthermore, luciferase reporter assay and RNA immunoprecipitation (RIP) assay were used to confirm the binding relationship between miR-320 and LINC00174. Additionally, western blot was used to detect the regulatory function of LINC00174 on oncogene S100 calcium binding protein A10 (S100A10). We demonstrated that LINC00174 expression in HCC clinical samples was significantly increased and this was correlated with higher T stage. Its overexpression remarkably accelerated proliferation and metastasis of HCC cells while reduced apoptosis. Accordingly, knockdown of it suppressed the malignant phenotypes of HCC cells. Overexpression of LINC00174 significantly reduced the expression of miR-320 by sponging it, in turn enhanced the expression of S100A10. In conclusion, LINC00174 is a sponge of tumour suppressor miR-320, enhances the expression of S100A10 indirectly and functions as an oncogenic lncRNA in HCC. SIGNIFICANCE OF THE STUDY: LINC00174 is a novel lncRNA, whose function is rarely investigated. It is reported that it is oncogenic in colorectal cancer, while its role in HCC remains unclear. Herein, we report that LINC00174 is significantly up-regulated in HCC tissues and promotes the malignant phenotypes. We demonstrate that LINC00174 functions as a sponge for miR-320, increases the expression level of oncogene S100A10 in HCC. This study helps clarify the mechanism of HCC tumorigenesis and progression, and uncover the role of LINC00174 in human disease.
© 2020 John Wiley & Sons Ltd.

Entities:  

Keywords:  LINC00174; S100A10; hepatocellular carcinoma; miR-320

Mesh:

Substances:

Year:  2020        PMID: 32128852     DOI: 10.1002/cbf.3498

Source DB:  PubMed          Journal:  Cell Biochem Funct        ISSN: 0263-6484            Impact factor:   3.685


  16 in total

1.  LINC00174 is a novel prognostic factor in thymic epithelial tumors involved in cell migration and lipid metabolism.

Authors:  Claudia Tito; Federica Ganci; Andrea Sacconi; Silvia Masciarelli; Giulia Fontemaggi; Claudio Pulito; Enzo Gallo; Valentina Laquintana; Alessia Iaiza; Luciana De Angelis; Anna Benedetti; Jessica Cacciotti; Selenia Miglietta; Maria Bellenghi; Alessandra Carè; Alessandro Fatica; Daniele Diso; Marco Anile; Vincenzo Petrozza; Francesco Facciolo; Gabriele Alessandrini; Edoardo Pescarmona; Federico Venuta; Mirella Marino; Giovanni Blandino; Francesco Fazi
Journal:  Cell Death Dis       Date:  2020-11-07       Impact factor: 8.469

2.  MiR-485-5p Suppress the Malignant Characteristics of the Lung Adenocarcinoma via Targeting NADPH Quinone Oxidoreductase-1 to Inhibit the PI3K/Akt.

Authors:  Yupeng Chen; Lin Wu; Min Bao
Journal:  Mol Biotechnol       Date:  2022-10-11       Impact factor: 2.860

3.  Promotion of BZW2 by LINC00174 through miR-4500 inhibition enhances proliferation and apoptosis evasion in laryngeal papilloma.

Authors:  Jiajia Liu; Tao Yang; Ying Zhang; Shuhui Wang
Journal:  Cancer Cell Int       Date:  2020-09-29       Impact factor: 5.722

4.  A potential prognostic prediction model of colon adenocarcinoma with recurrence based on prognostic lncRNA signatures.

Authors:  Lipeng Jin; Chenyao Li; Tao Liu; Lei Wang
Journal:  Hum Genomics       Date:  2020-06-10       Impact factor: 4.639

5.  Exosomal LINC00174 derived from vascular endothelial cells attenuates myocardial I/R injury via p53-mediated autophagy and apoptosis.

Authors:  Qiang Su; Xiang-Wei Lv; Yu-Li Xu; Ru-Ping Cai; Ri-Xin Dai; Xi-Heng Yang; Wei-Kun Zhao; Bing-Hui Kong
Journal:  Mol Ther Nucleic Acids       Date:  2021-02-10       Impact factor: 8.886

6.  Comprehensive Analysis of the Prognosis and Correlations With Immune Infiltration of S100 Protein Family Members in Hepatocellular Carcinoma.

Authors:  Susu Zheng; Linxia Liu; Tongchun Xue; Chuyu Jing; Xin Xu; Yanfang Wu; Meixia Wang; Xiaoying Xie; Boheng Zhang
Journal:  Front Genet       Date:  2021-03-18       Impact factor: 4.599

Review 7.  Hepigenetics: A Review of Epigenetic Modulators and Potential Therapies in Hepatocellular Carcinoma.

Authors:  Mohamed H Yousef; Hassan A N El-Fawal; Anwar Abdelnaser
Journal:  Biomed Res Int       Date:  2020-11-24       Impact factor: 3.411

8.  LINC00174 Facilitates Cell Proliferation, Cell Migration and Tumor Growth of Osteosarcoma via Regulating the TGF-β/SMAD Signaling Pathway and Upregulating SSH2 Expression.

Authors:  Changjun Zheng; Ronghang Li; Shuang Zheng; Hongjuan Fang; Meng Xu; Lei Zhong
Journal:  Front Mol Biosci       Date:  2021-06-17

9.  Long non‑coding RNA MKLN1‑AS aggravates hepatocellular carcinoma progression by functioning as a molecular sponge for miR‑654‑3p, thereby promoting hepatoma‑derived growth factor expression.

Authors:  Wanjun Gao; Xiaohua Chen; Wei Chi; Ming Xue
Journal:  Int J Mol Med       Date:  2020-09-09       Impact factor: 4.101

10.  MicroRNA hsa-miR-150-5p inhibits nasopharyngeal carcinogenesis by suppressing PYCR1 (pyrroline-5-carboxylate reductase 1).

Authors:  Zhiqun Li; Xiaoliu Zhou; Jiajun Huang; Zhencai Xu; Chengliang Xing; Junwei Yang; Xuejun Zhou
Journal:  Bioengineered       Date:  2021-12       Impact factor: 3.269

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.